awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35237773-15449536-7747-409A-9CAB-6A07DD184E31
Q35237773-15449536-7747-409A-9CAB-6A07DD184E31
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35237773-15449536-7747-409A-9CAB-6A07DD184E31
Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-EGFR] in Dual-combination with Epirubicin-(C3-amide)-[anti-HER2/neu] against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3) and the Complementary Effect of Mebendazole.
P2860
Q35237773-15449536-7747-409A-9CAB-6A07DD184E31
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35237773-15449536-7747-409A-9CAB-6A07DD184E31
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
72947418c653a38ea43bbbcf072804a69ee6903d
P2860
Acquired resistance to small molecule ErbB2 tyrosine kinase inhibitors.